Natco Pharma Limited — Others, 28-05-2025: Change in Management

Natco Pharma has announced a board meeting that approved appointing BK & Associates as Secretarial Auditors for five years, pending shareholder approval. Key leadership changes effective June 1, 2025 include new Vice President and Associate Vice Presidents across Corporate Quality Assurance, Operations, Regulatory Affairs, and Distribution. These strategic appointments aim to enhance management strength and support operational efficiency and compliance, reinforcing Natco’s focus on maintaining robust quality and regulatory standards.